These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Peritoneum as a dialysis membrane. II. Pathology]. Grzybowski A; Breborowicz A Przegl Lek; 1997; 54(1):52-61. PubMed ID: 9190636 [TBL] [Abstract][Full Text] [Related]
3. What is new in peritoneal dialysis in the years 2003-2004. Grzegorzewska AE Rocz Akad Med Bialymst; 2004; 49():170-3. PubMed ID: 15631336 [TBL] [Abstract][Full Text] [Related]
4. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968 [TBL] [Abstract][Full Text] [Related]
6. [Automated peritoneal dialysis: impact on residual kidney function and peritoneal membrane permeability]. Gallar P; Ortega O; Gutiérrez M; Carreño A; Domínguez-Gil B; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A Nefrologia; 2001; 21(2):200-3. PubMed ID: 11464654 [No Abstract] [Full Text] [Related]
7. [Prevention of malnutrition in peritoneal dialysis patients]. Lobbedez T; Pujo M; el Haggan W; Hurault de Ligny B; Levaltier B; Ryckelynck JP Nephrologie; 2003; 24(7):387-9. PubMed ID: 14650752 [TBL] [Abstract][Full Text] [Related]
8. For how long can peritoneal dialysis be continued? Oreopoulos DG; Gotloib L; Calderaro V; Khanna R Can Med Assoc J; 1981 Jan; 124(1):12-4. PubMed ID: 7459766 [No Abstract] [Full Text] [Related]
9. What are the problems with using the peritoneal membrane for long-term dialysis? Bargman JM; Krediet RT; Lo WK; Selgas R; del Peso G; Auxiliadora Bajo M; Mujais S Semin Dial; 2008; 21(1):11-23. PubMed ID: 18251949 [No Abstract] [Full Text] [Related]
10. Peritoneal membrane structural and functional changes during peritoneal dialysis. Goffin E Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. I. Intraperitoneal or intravenous use of furosemide during intermittent peritoneal dialysis]. Grzegorzewska A Przegl Lek; 1988; 45(4):365-73. PubMed ID: 3212200 [No Abstract] [Full Text] [Related]
12. [The effect of drugs on peritoneal dialysis clearance]. Djukanović Lj; Ikonomovski J; Milovanović D Srp Arh Celok Lek; 1984 Jan; 112(1):115-26. PubMed ID: 6505849 [No Abstract] [Full Text] [Related]
13. [Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. II. Intraperitoneal administration of sodium nitroprusside during intermittent peritoneal dialysis]. Grzegorzewska A Przegl Lek; 1988; 45(6):485-90. PubMed ID: 3252349 [No Abstract] [Full Text] [Related]
19. [Determination of substances of middle molecular mass in the body fluids of patients treated with intermittent peritoneal dialysis]. Dukanović L; Petrović J Lijec Vjesn; 1982; 104(11-12):527-9. PubMed ID: 7187480 [No Abstract] [Full Text] [Related]
20. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics. Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]